Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Cancer Patients Who Receive Neoadjuvant Therapy Followed By Mastectomy May Not Need Radiation
http://www.medicalnewstoday.com/articles/123039.php
Early-stage breast cancer patients who exhibit limited lymph node involvement may not require post-surgery radiation therapy (RT) when they receive neoadjuvant chemotherapy before a mastectomy, according to researchers from The University of Texas M.
Young Women With Early Form Of Breast Cancer No More Likely To Experience Recurrence Than Older Women
http://www.medicalnewstoday.com/articles/122994.php
Young women with DCIS, a common form of early breast cancer that arises in and is confined to the mammary ducts, are presumed more likely to have recurrences than older women with the same diagnosis.
Study Finds Shorter Intensive Radiation Therapy Effective In Treating Early-Stage Breast Cancer
http://www.medicalnewstoday.com/articles/122951.php
<BR />Three weeks of intensive radiation therapy is as effective as or more effective than the standard five weeks of therapy in the treatment of early-stage breast cancer, according to a study presented on Monday at a meeting of the <A href="http://www.
House Committee Approves Amended Bill On Research On Environmental Effects Of Breast Cancer
http://www.medicalnewstoday.com/articles/122947.php
House Committee Approves Amended Bill on Research on Environmental Effects of Breast Cancer<BR />A bill (<A href="http://thomas.loc.gov/cgi-bin/bdquery/z?d110:h.r.01157:" target=_new>HR 1157</A>) that would increase federal funding and research into understanding the environmental causes of breast cancer was amended on Tuesday by the House Energy and Commerce Committee, <CITE>CQ Today</CITE> reports.
Study Shows Radiation Device May Customize Therapy, Enable Some To Avoid More Lengthy Treatment
http://www.medicalnewstoday.com/articles/122849.php
A study of the first approximately 100 patients who have received partial breast irradiation with a small, whisk-like, expandable device inserted inside the breast has shown that after one year, the device is effective at sparing nearby healthy tissue from the effects of radiation.
----------------------------------------------
** CANCER / ONCOLOGY News **
Initiation Of Clinical Trials Of CPI-613 For The Treatment Of Cancer - First-In-Class Altered Energy Metabolism-Directed Compound
http://www.medicalnewstoday.com/articles/123053.php
Cornerstone Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has begun dosing patients in a recently approved safety and early efficacy clinical trial of CPI-613, its novel first-in-class Altered Energy Metabolism-Directed (AEMD) compound being evaluated for potential use in a wide array of cancers.
Celsion Provides Update On Its Global Pivotal Phase III Primary Liver Cancer Trial
http://www.medicalnewstoday.com/articles/123050.php
Celsion Corporation (NASDAQ: CLSN) announced today that its global Phase III Primary Liver Cancer trial is proceeding as planned. In addition to the receipt of FDA agreement in January of 2008 for our pivotal Phase III Primary Liver Cancer trial in the United States, the Company reports that it has obtained regulatory approval to conduct its study titled "A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination with Radiofrequency Ablation (RFA) Compared to RFA Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma (HCC)" in Hong Kong, Taiwan, Korea, Canada, and Italy, and anticipates that a Clinical Trial Agreement will be obtained in China before the end of 2008.
Delcath Adds Providence Cancer Center To Phase III Trial - Robert W. Franz Cancer Research Center Is 2nd West Coast Center
http://www.medicalnewstoday.com/articles/123014.php
Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the Robert W. Franz Cancer Research Center, a part of the Providence Cancer Center, located in Portland, Oregon, has joined Delcath's Phase III clinical trial for the treatment of inoperable metastatic melanoma in the liver using the Company's Percutaneous Hepatic Perfusion (PHP) System.
Lance Armstrong Unveils Global Cancer Awareness Campaign And Details Of His Return To Cycling
http://www.medicalnewstoday.com/articles/123013.php
Today, Lance Armstrong, cancer survivor, cycling champion and founder and chairman of the Lance Armstrong Foundation (LAF), announced the creation of the LIVESTRONG(TM) Global Cancer Awareness Campaign focused on supporting the 25 million people living with cancer worldwide, dispelling the misconceptions surrounding the disease and urging world leaders to make cancer a greater priority.
Molecular Imaging Technology Used In Gastric Cancer
http://www.medicalnewstoday.com/articles/123005.php
Modern cancer care is critically dependent on imaging technologies, which are used to detect early tumors and guide their therapy or surgery. Molecular imaging technologies provide information about the functional or metabolic characteristics of malignancies, tumor stage and therapeutical response, and tumor recurrence; whereas conventional imaging technologies predominantly assess the tumor's anatomical or morphologic features including its size, density, shape, etc.
Life-Extending Kidney Cancer Drug Commended For Health Benefit And Innovation
http://www.medicalnewstoday.com/articles/122993.php
Torisel ® (temsirolimus), Wyeth's innovative new treatment for poor prognosis advanced renal cell (kidney) cancer, has been commended at the 2008 UK Prix Galien. The commendation was made in the Prix Galien's new 'orphan drug' category, introduced this year for the first time to recognise advances in treating rarer diseases.
PM Announcement That Prescription Charge Exemptions Will Be Extended - NPA Reaction
http://www.medicalnewstoday.com/articles/122989.php
Commenting on the Prime Minister's announcement at the Labour Party conference about extending prescription charge exemptions to people with cancer in April 2009 and eventually to all people with long term conditions, John Turk, Chief Executive of the National Pharmacy Association said:"The NPA has long called for a review of prescription charges and we are pleased to see this is now underway.
The King's Fund Welcomes The Prime Minister's Announcement On Prescription Charges, UK
http://www.medicalnewstoday.com/articles/122986.php
'This is a welcome move. The current system is confusing, unfair and illogical - today's announcement by the Prime Minister will help some of the most vulnerable patients with cancer and eventually those with other long-term conditions.
Reducing Open Cancer Surgery
http://www.medicalnewstoday.com/articles/122903.php
The surgeon's knife is playing an ever smaller role in the treatment of cancer, as it is replaced by increasingly efficient and safe radiation therapy techniques. Progress in radiation technology will also lead to better detection rates for cancer.
Roswell Park Awarded Funds To Study Intra-Operative Staging Of Lung Cancer
http://www.medicalnewstoday.com/articles/122856.php
Chukwumere E. Nwogu, MD, Department of Surgery at Roswell Park Cancer Institute, has been awarded grants from has been awarded grants from the <a href="http://www.cancer.gov/" target="_blank" rel="nofollow">National Cancer Institute </a> and the <a href="http://www.
Ovarian And Endometrial Cancer Patients Experience Improved Outcomes When Treated First By A Gynecologic Oncologist
http://www.medicalnewstoday.com/articles/122851.php
For the first time, accumulated data demonstrates that women diagnosed with a reproductive cancer, especially ovarian and uterine (endometrial) cancers, experience improved outcomes when treated first by a gynecologic oncologist.
Experts Assert That Varian Technologies Deliver Speed And Clinical Accuracy In Treating Cancer Patients
http://www.medicalnewstoday.com/articles/122813.php
Cancer treatment specialists reported yesterday how new technologies are enabling them to provide faster, more accurate cancer treatments than was possible with earlier generations of radiotherapy technology.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Seeking The Most Accurate Diagnosis Of Rectal Carcinoma
http://www.medicalnewstoday.com/articles/123046.php
The depth of transmural tumor invasion along the rectal wall layers and involvement of the regional lymph nodes constitutes major factors in the prognosis of rectal cancer. Therefore accurate preoperative staging of rectal cancer carries a crucial importance in terms of therapy and prognosis.
LOH Analysis On 4q In Sporadic Colorectal Carcinoma
http://www.medicalnewstoday.com/articles/122998.php
Thirteen fluorescent labeled polymorphic microsatellite markers were analyzed in 83 cases of colorectal carcinoma and matched normal tissue DNA by polymerase chain reaction (PCR). PCR products were eletrophoresed on an ABI 377 DNA sequencer.
Blacks Have Greater Risk For Larger, Difficult-To-Detect Colon Polyps Than Whites, Study Finds
http://www.medicalnewstoday.com/articles/122977.php
Blacks are at higher risk than whites for having large precancerous polyps in their colons, according to a study published in this week's <cite>Journal of the American Medical Association</cite>, <a href="http://www.
----------------------------------------------
** LUNG CANCER News **
Roswell Park Awarded Funds To Study Intra-Operative Staging Of Lung Cancer
http://www.medicalnewstoday.com/articles/122856.php
Chukwumere E. Nwogu, MD, Department of Surgery at Roswell Park Cancer Institute, has been awarded grants from has been awarded grants from the <a href="http://www.cancer.gov/" target="_blank" rel="nofollow">National Cancer Institute </a> and the <a href="http://www.
BioView Reports Interim Results Of Early Detection Lung Cancer Diagnostic Test
http://www.medicalnewstoday.com/articles/122818.php
BioView Ltd, (TASE: BIOV) from Rehovot, Israel, reported results of its internal clinical trial of the non-invasive diagnostic test under development for early detection of lung cancer. <b>In the trial a total of 76 sputum samples were collected from four groups of patients:</b> 1.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
No news for this category today.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
Ipsen Announces The Filing Of Decapeptyl(R) 6-month Formulation For The Treatment Of Locally Advanced Or Metastatic Prostate Cancer
http://www.medicalnewstoday.com/articles/123023.php
Ipsen (Euronext: FR0010259150; Paris: IPN) announced the start of the filing process in Europe of the 6-month sustained release formulation of Decapeptyl®, a luteinizing hormone releasing hormone agonist (LHRHa) developed by Debiopharm for the treatment of locally advanced or metastatic hormone-dependent prostate cancer.
bioMérieux To Develop New Highly-Specific, Non-Invasive Test For Prostate Cancer, Reducing Unnecessary Biopsies
http://www.medicalnewstoday.com/articles/123016.php
Prostate cancer is the most prevalent cancer in the United States and the 4th most common worldwide. The combination of a test for a new prostate cancer biomarker, Annexin 3, with the standard screening methods could potentially reduce the number of biopsies conducted by up to 75%, when compared with current screening methods alone.
Whether To Treat Prostate Cancer With Hormones Should Not Hinge On Age Alone
http://www.medicalnewstoday.com/articles/122992.php
Concerns regarding the association of hormone therapy used to treat prostate cancer with cardiovascular disease in some older men may lead doctors to forgo hormone treatment solely on the basis of age.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment